Tango Therapeutics Inc Cash Flow Reinvestment Rate

Latest as of September 2020: 0.63x

Tango Therapeutics Inc cash flow reinvestment rate. Tango Therapeutics Inc (TNGX) has a Cash Flow Reinvestment Rate of 0.63x as of September 2020, reinvesting $69.75 Million (capex $132.00K plus investments $-69.62 Million) from operating cash flow of $111.26 Million. Explore TNGX operating cash to total liabilities to assess how comfortably operating cash covers total debt obligations.

Reinvestment Rate

0.63x

(Capex + Investments) / Operating CF

Total Reinvested

$69.75 Million

Capex + Investments

Operating Cash Flow

$111.26 Million

USD

Capital Expenditures

$132.00K

USD

Cash Flow Reinvestment Rate of Tango Therapeutics Inc (2020–2020)

Cash flow reinvestment rate of Tango Therapeutics Inc from 2020 to 2020. Historical reinvestment intensity for Tango Therapeutics Inc across 1 annual periods. Explore Tango Therapeutics Inc (TNGX) reinvestment ratio to see what proportion of operating cash flow is directed to capital expenditures.

Tango Therapeutics Inc Cash Flow Reinvestment Rate by Year (2020–2020)

Tango Therapeutics Inc cash flow reinvestment rate by year from 2020 to 2020. Year-by-year capital reinvestment analysis for Tango Therapeutics Inc. For the full cash flow conversion analysis, see cash flow conversion of Tango Therapeutics Inc.

Year	Reinvestment Rate	Total Reinvested (USD)	Operating CF	Capex	YoY Change
2020	2.08x	$145.43 Million	$70.07 Million	$1.11 Million	—

Cash Flow Reinvestment Rate = (ABS(Capex) + ABS(Investments)) / Operating Cash Flow